Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma.

ABSTRACT:

SUBMITTER: Pikman Y 

PROVIDER: S-EPMC7160286 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature